What You Need to Know About Fortrea Holdings Inc.'s Q3 Earnings
Fortrea Holdings Inc.'s fiscal Q3 earnings report was released on Wednesday, July 29. Let's dive in to see if (FTRE) missed or beat analyst's expectations.Rosalio Madrigal
Stock Evaluator: Fortrea Holdings Inc. (FTRE)
Fortrea Holdings Inc. FTRE
$19.17
0.09
0.47%
July 31, 2026 4:00:00 PM
EST
Volume: 1,914,144
After Hours: $120.37
0.15
|
0.12%
November 10, 2021 7:59 PM
EST
Volume: 72,713
USD
NASD | DELAYED PRICE
| SECTOR | INDUSTRY |
| Health Care | Life Sciences Tools & Services |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical pharmacology, such as clinical research units, external partnerships, project management, study design and monitoring, bioanalytics and biomarkers, pharmacokinetics, modeling and simulation, and biometrics; and clinical development, including phase I through IV clinical and real-world evidence studies, regulatory affairs, protocol design, operational planning, study and site start-up, patient recruitment, project management, comprehensive site and medical monitoring, data management and biostatistics, pharmacovigilance, medical writing, and mobile clinical services. The company also provides consulting services comprising product development and regulatory, market access and health economics, and outcomes research, as well as RWE services. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Commentary & Analysis
Why Fortrea Holdings Inc.’s (FTRE) Stock Is Up 6.90%
As of Tuesday, July 28, Fortrea Holdings Inc.’s FTRE share price has surged by 6.90%, which has investors questioning if this is right time to sell.Michael Rose
Why Fortrea Holdings Inc.’s (FTRE) Stock Is Up 5.92%
As of Thursday, July 23, Fortrea Holdings Inc.’s FTRE share price has surged by 5.92%, which has investors questioning if this is right time to sell.Michael Rose
Why Fortrea Holdings Inc.’s (FTRE) Stock Is Up 5.76%
As of Thursday, June 25, Fortrea Holdings Inc.’s FTRE share price has surged by 5.76%, which has investors questioning if this is right time to sell.Rosalio Madrigal
Why Fortrea Holdings Inc.’s (FTRE) Stock Is Up 5.41%
As of Wednesday, June 24, Fortrea Holdings Inc.’s FTRE share price has surged by 5.41%, which has investors questioning if this is right time to sell.Cynthia McLaughlin
Financial Summary
| Share Statistics | FTRE | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,823.1 | $1,790.4 | 53% |
|
| Shares Out (Mil) | 94.8 | 94.8 | 61% |
|
| Institutional Ownership | 99.2% | 90.0% | 86% |
|
| Float (Mil) | 94.2 | 69.9 | 60% |
|
| Beta | 2.01 | 1.20 | 92% |
|
| Avg Daily Volume (000s) | 1,811 | 814 | 80% |
|
| Price Change (52-week) |
209.2% | 80.2% | 97% |
|
| Growth | FTRE | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 1.1% | 7.8% | 20% |
|
| Net Income (5yr) | (22.4%) | (13.7%) | 18% |
|
| EPS (5yr) | na | 0.7% | na |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | na | (15.0%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 10 | 11 | 12 | |
| Current EPS | $0.214 | $0.845 | $1.141 | |
| Month Ago EPS | $0.206 | $0.807 | $1.077 | |
| # Rev Up | 1 | 0 | 0 | |
| # Rev Down | 0 | 0 | 0 | |
| Three Months Ago EPS | $0.219 | $0.707 | $0.940 | |
| Year/Year Chg | (254.0%) | (107.8%) | (113.0%) | |
| Financials | FTRE | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $2,677 | $785 | 65% |
|
| Net Income (TTM) (Mil) | ($85) | ($14) | 12% |
|
| EPS (TTM) | ($0.915) | ($0.200) | 22% |
|
| Operating Cash Flow (TTM) (Mil) | $228 | $53 | 61% |
|
| Net Cash Flow (TTM) (Mil) | na | ($4) | na |
|
| Long-Term Debt (Q1) (Mil) | $1,092 | $270 | 67% |
|
| Enterprise Value (Q1) (Mil) | $2,764 | $2,444 | 53% |
|
| Valuation | FTRE | Industry Median |
Percentile (All Stocks) |
|
| P/B | 3.48 | 2.92 | 69% |
|
| P/E | na | 43.7 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 5.3 | na |
|
| Ratios | FTRE | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 19.3% | 47.6% | 20% |
|
| Net Margin | (3.2%) | (2.9%) | 27% |
|
| ROA | (3.1%) | (2.8%) | 32% |
|
| ROE | (15.3%) | (4.5%) | 25% |
|
| Liabilities to Assets | 80.7% | 43.0% | 75% |
|
| F-Score | 4 | 5 | 34% |
|
Passing Stock Screens
As of 7/31/2026, from a list of 60 stock screening strategies,
GURU STRATEGY
Kirkpatrick Bargain Screen
Factors: Value, Momentum
Investing model outlined in Charles Kirkpatrick's book, Beat the Market: Invest by Knowing What Stocks to Buy and What Stocks to Sell.
| Performance Since Inception: | 6.8% |
| +/- S&P 500: | -0.7 |
GURU STRATEGY
O'Shaughnessy: Growth Screen II
Factors: Value, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 15.1% |
| +/- S&P 500: | +7.6 |
GURU STRATEGY
O'Shaughnessy: Small Cap Growth & Value Screen
Factors: Value, Size, Momentum
O'Shaughnessy tries to predict the future using historical long-term trends.
| Performance Since Inception: | 17.3% |
| +/- S&P 500: | +9.8 |
GURU STRATEGY
Driehaus Revised Screen
Factors: Size, Momentum, Growth, Earnings Estimates
Revisiting the approach of the "father of momentum investing," Richard Driehaus, that seeks out companies with accelerating earnings growth, rising earnings estimates and meaningful positive earnings surprises.
| Performance Since Inception: | 18.2% |
| +/- S&P 500: | +10.7 |
